![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Molecular Pharmacology, Vol 10, 349-359, Copyright © 1974 by the American Society for Pharmacology and Experimental Therapeutics
1 Department of Pharmacology and Toxicology, University of Rochester School of Medicine and
Dentistry, Rochester, New York 14642
The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) on the induction of microsomal oxygenase were studied in the rat. TCDD was 3 x 104 times more potent than 3-methylcholanthrene (MC) as an inducer of hepatic aryl hydrocarbon hydroxylase. Half-maximal induction occurred at a dose of 0.85 nmole/kg. TCDD and MC produced parallel log dose-response curves for the induction of hepatic aryl hydrocarbon hydroxylase, with the same maximal response. The simultaneous administration of maximally inducing doses of both drugs produced no greater response than either drug alone. TCDD, like MC, induced a spectrally distinct type of cytochrome P-450, with a shift in the absorption maximum of the carbon monoxide difference spectrum from 450 nm to 448 nm, and an increase in the ratio of the 455 nm:430 nm absorption maxima of the ethyl isocyanide difference spectra. Following a single dose of TCDD (31.1 nmoles/kg), hepatic aryl hydrocarbon hydroxylase activity and microsomal hemoprotein remained elevated for over 35 days. Both TCDD and MC had little effect on hepatic aminopyrine N-demethylase and NADPH-cytochrome c reductase. The dose of TCDD which produced half-maximal induction of hepatic aryl hydrocabon hydroxylase in the rat, chick embryo, and several strains of mice was similar, varying from 0.4 to 1.2 nmoles/kg.
Submitted on December 3, 1973
This article has been cited by other articles:
|
|
 |
|
  A. B. Okey An Aryl Hydrocarbon Receptor Odyssey to the Shores of Toxicology: The Deichmann Lecture, International Congress of Toxicology-XI Toxicol. Sci., July 1, 2007; 98(1): 5 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ma and A. Y. H. Lu CYP1A Induction and Human Risk Assessment: An Evolving Tale of in Vitro and in Vivo Studies Drug Metab. Dispos., July 1, 2007; 35(7): 1009 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. E. Bohonowych and M. S. Denison Persistent Binding of Ligands to the Aryl Hydrocarbon Receptor Toxicol. Sci., July 1, 2007; 98(1): 99 - 109. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Q. Ma Aryl Hydrocarbon Receptor Degradation-Promoting Factor (ADPF) and the Control of the Xenobiotic Response Mol. Interv., June 1, 2007; 7(3): 133 - 137. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Andrieux, S. Langouet, A. Fautrel, F. Ezan, J. A. Krauser, J. F. Savouret, F. P. Guengerich, G. Baffet, and A. Guillouzo Aryl Hydrocarbon Receptor Activation and Cytochrome P450 1A Induction by the Mitogen-Activated Protein Kinase Inhibitor U0126 in Hepatocytes Mol. Pharmacol., April 1, 2004; 65(4): 934 - 943. [Abstract] [Full Text]
|
|
|
|
 |
|
 S. R. Kondraganti, W. Jiang, and B. Moorthy Differential Regulation of Expression of Hepatic and Pulmonary Cytochrome P4501A Enzymes by 3-Methylcholanthrene in Mice Lacking the CYP1A2 Gene J. Pharmacol. Exp. Ther., December 1, 2002; 303(3): 945 - 951. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Shimada, K. Inoue, Y. Suzuki, T. Kawai, E. Azuma, T. Nakajima, M. Shindo, K. Kurose, A. Sugie, Y. Yamagishi, et al. Arylhydrocarbon receptor-dependent induction of liver and lung cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic hydrocarbons and polychlorinated biphenyls in genetically engineered C57BL/6J mice Carcinogenesis, July 1, 2002; 23(7): 1199 - 1207. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Gambone, J. M. Hutcheson, J. L. Gabriel, R. L. Beard, R. A.S. Chandraratna, K. J. Soprano, and D. R. Soprano Unique Property of Some Synthetic Retinoids: Activation of the Aryl Hydrocarbon Receptor Pathway Mol. Pharmacol., February 1, 2002; 61(2): 334 - 342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Moorthy Persistent Expression of 3-Methylcholanthrene-Inducible Cytochromes P4501A in Rat Hepatic and Extrahepatic Tissues J. Pharmacol. Exp. Ther., July 1, 2000; 294(1): 313 - 322. [Abstract] [Full Text]
|
|
|
|
 |
|
 E. McConnell, G. Lucier, R. Rumbaugh, P. Albro, D. Harvan, Hass JR, and M. Harris Dioxin in soil: bioavailability after ingestion by rats and guinea pigs Science, March 9, 1984; 223(4640): 1077 - 1079. [Abstract] [PDF]
|
|
|
|
|
|
H Shichi, D. Gaasterland, N. Jensen, and D. Nebert Ah locus: genetic differences in susceptibility to cataracts induced by acetaminophen Science, May 5, 1978; 200(4341): 539 - 541. [Abstract] [PDF]
|
|
|
|
|
|
A Poland, E Clover, A. Kende, M DeCamp, and C. Giandomenico 3,4,3',4'-Tetrachloro azoxybenzene and azobenzene: potent inducers of aryl hydrocarbon hydroxylase Science, November 5, 1976; 194(4265): 627 - 630. [Abstract] [PDF]
|
|
 |
 |
 |
|
 |
 |
 |
